Bridget Morse is a highly experienced professional in quantitative clinical pharmacology, currently serving as a Senior Scientific Director at Eli Lilly and Company since February 2016. Bridget has advanced through various roles at Eli Lilly, including Director, Principal Research Scientist, and Senior Research Scientist, all focused on drug disposition. Prior to Eli Lilly, Bridget worked as a Research Investigator at Bristol Myers Squibb from April 2014 to January 2016 and completed a postdoctoral fellowship at Western University in 2013. Bridget holds a Doctor of Philosophy in Pharmaceutical Sciences from the University at Buffalo and a Doctor of Pharmacy from Butler University.
This person is not in any teams
This person is not in any offices